Brian Finrow

Seattle, Washington,
Brian Finrow brings the skills and experience of a lawyer to a position that, in the biotech world, is more typically occupied by a scientist. This is essential to an enterprise like Lumen, which is rethinking drug development from the ground up to emphasize speed, efficiency and ease of delivery, and whose approach is so innovative that traditional ways of thinking about IP and regulatory pathways oftentimes do not apply.
Prior to co-founding Lumen, Brian oversaw complex negotiations with various major biopharma companies and managed IP strategy for Adaptive Biotechnologies, where he was SVP and General Counsel. As senior attorney at the law firm Cooley LLC, his practice focused on equity financing and M&A transactions, and negotiating complex biotech licensing and collaboration deals. With over 15 years of legal and commercial experience at these market-leading, innovative firms, he is well positioned to develop creative, win-win deal structures with partners.
Harvard Law, JD
Speaking In
1:00 PM - 2:35 PM (PDT)
Monday, June 13
Tech R&D investments are increasingly looking to tackle issues in cell and gene therapy…
4:30 PM - 4:45 PM (PDT)
Tuesday, June 14
Lumen Bio is a clinical-stage biotechnology company that discovers, develops, and manufactures…